Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hiroya, Narumi"'
Autor:
Hiroya, Narumi, Hiroyuki, Takano, Satoshi, Shindo, Miwa, Fujita, Hiroshi, Mizuma, Yoichi, Kuwabara, Issei, Komuro
Publikováno v:
Hypertension research : official journal of the Japanese Society of Hypertension. 40(1)
Autor:
Hiroya, Narumi, Hiroyuki, Takano, Satoshi, Shindo, Miwa, Fujita, Hiroshi, Mizuma, Yoichi, Kuwabara, Issei, Komuro, Katsuya, Yoshida
Publikováno v:
Hypertension Research. 34:62-69
The Valsartan Amlodipine Randomized Trial, a multicenter, prospective, randomized, open-labeled, blinded-end point trial, was designed to compare the beneficial effects of the angiotensin II receptor blocker valsartan and the calcium channel blocker
Autor:
Nobusada Funabashi, Shouji Yoshida, Isao Umehara, Issei Komuro, Katsuya Yoshida, Naotake Hashimoto, Hiroya Narumi
Publikováno v:
International Journal of Cardiology. 135:150-155
To evaluate the clinical role of subcutaneous fat accumulation in subclinical arteriosclerosis, using computed tomography (CT), we measured the subcutaneous fat area (SFA), the visceral fat area (VFA) and the VFA/SFA ratio and compared these with the
Autor:
Hiroshi Mizuma, Keiko Nakayama, Yoichi Kuwabara, Satoshi Shindo, Masao Daimon, Issei Komuro, Miwa Fujita, Hiroya Narumi
Publikováno v:
Hypertension Research. 31:21-28
Antihypertensive therapy has been well established to reduce hypertension related morbidity and mortality, but the optimal therapy for Japanese patients remains unknown. The Valsartan Amlodipine Randomized Trial (VART), a prospective randomized open-
Autor:
Nobusada Funabashi, Miki Asano, Yuzuru Mita, Fumiaki Maeda, Hiroya Narumi, Kazushi Suzuki, Michiko Kurokawa, Issei Komuro, Kohki Nakamura
Publikováno v:
International Journal of Cardiology. 111:333-335
Autor:
Yoshio Kobayashi, Issei Komuro, Takao Namiki, Hiroshi Hasegawa, Hiroyuki Takano, Hiroya Narumi, Masashi Ohtsuka, Tadahiko Mizuguchi
Publikováno v:
Hypertension research : official journal of the Japanese Society of Hypertension. 34(11)
The Telmisartan and Losartan Cardiac Evaluation Trial, a multicenter, prospective, randomized, open-labeled, blinded-endpoint trial, was designed to compare the effects of two angiotensin II receptor blockers (ARBs), telmisartan and losartan, on card
Autor:
Hiroya Narumi, Katsuya Yoshida, Nobusada Funabashi, Naotake Hashimoto, Isao Umehara, Shouji Yoshida, Issei Komuro
Publikováno v:
Circulation. 118
Background: Augmented metabolic activity of macrophages leads to enough F-18 Fluorodeoxyglucose (FDG) uptake to allow visualization by positron emission tomography (PET). A large body of data, based on computed tomography (CT), has also accumulated c
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 66(8)
Guidelines for the management of hypertension are established to reduce hypertension-related morbidity and mortality. Fundamental aims of interventions are designed to prevent and/or slow the development of cardiovascular diseases such as myocardial
Autor:
Koichi Node, Hiroya Narumi, Daisuke Fujimatsu, Yoichi Kuwabara, Teruo Inoue, Hiroshi Mizuma, Issei Komuro, Hiroyuki Takano, Satoshi Shindo
Publikováno v:
Journal of Cardiac Failure. 14:S133